Results 41 to 50 of about 6,682 (214)

Changes in cardiac sympathetic nerve activity on 123I‐metaiodobenzylguanidine scintigraphy after MitraClip therapy

open access: yesESC Heart Failure, 2021
Aims In patients with heart failure, over‐activation of the cardiac sympathetic nerve (CSN) function is associated with severity of heart failure and worse outcome.
Keisuke Fukuda   +6 more
doaj   +1 more source

Renal sympathetic nerve activity after catheter-based renal denervation

open access: yesEJNMMI Research, 2018
Background Catheter-based renal sympathetic denervation (RDN) has been considered a potential treatment for therapy resistant hypertension (RHT). However, in a randomized placebo-controlled trial, RDN did not lead to a substantial blood pressure (BP ...
Linn C. Dobrowolski   +8 more
doaj   +1 more source

Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 2005
To evaluate the reliability of [(123)I]meta-iodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease (PD).A series of 391 outpatients showing one or more parkinsonian-like symptoms was longitudinally followed up for accurate clinical diagnosis.
H, Nagayama   +4 more
openaire   +2 more sources

The Pediatric Neuroblastoma: Application of MIBG Scintigraphy in Diagnosis, Staging, and Follow-up – Analysis of Three Cases

open access: yesSwiss Journal of Radiology and Nuclear Medicine
Introduction: Neuroblastoma is the most common extracranial solid tumor in children, accounting for 8-10% of all pediatric cancers. Accurate diagnosis and management rely on imaging modalities and biological markers such as elevated urinary ...
Mohammed Otmane, Nadia Alaoui Ismaili
doaj   +1 more source

Complete remission of metastatic pheochromocytoma in 123I-metaiodobenzylguanidine scintigraphy after a single session of 131I-metaiodobenzylguanidine therapy: a case report

open access: yesBMC Research Notes, 2017
Background Pheochromocytomas are rare neuroendocrine tumors, with a malignancy frequency of approximately 10%. The treatment of malignant pheochromocytoma is palliative, and the traditional management strategy has limited efficacy.
Teruaki Sugino   +15 more
doaj   +1 more source

123-Iodine MIBG in the Assessment of Sympathetic Denervation in Ogilvie's Syndrome

open access: yesWorld Journal of Nuclear Medicine, 2022
123-Iodine metaiodobenzylguanidine (I-123 MIBG) imaging is frequently used in the assessment of sympathetic innervation and autonomic dysfunction in patients with cardiac failure, neurodegenerative Parkinson's syndrome, multiple system atrophy, myotonic ...
Amit Bhoil, Sobhan Vinjamuri
doaj   +1 more source

Cardiac sympathetic dysfunction in pulmonary arterial hypertension: Lesson from left-sided heart failure [PDF]

open access: yes, 2019
Sympathetic nervous system hyperactivity has a well-recognized role in the pathophysiology of heart failure with reduced left ventricular ejection fraction.
Bonaduce, Domenico   +10 more
core   +1 more source

Neuroendocrine tumours of the head and neck: anatomical, functional and molecular imaging and contemporary management [PDF]

open access: yes, 2013
Neuroendocrine tumours (NETs) of the head and neck are rare neoplasms and can be of epithelial or non-epithelial differentiation. Although the natural history of NETs is variable, it is crucial to establish an early diagnosis of these tumours as they can
Chowdhury, F   +4 more
core   +1 more source

Nonmotor Symptoms in Patients with PARK2 Mutations

open access: yesParkinson's Disease, 2011
Decreased 123I-meta-iodobenzylguanidine (MIBG) uptake in MIBG myocardial scintigraphy, olfactory dysfunction, and rapid eye movement (REM) sleep behavior disorder (RBD) are considered useful early indicators of Parkinson disease.
Asako Yoritaka   +5 more
doaj   +1 more source

Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical Practice

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Reduced cardiac uptake on 123Iodine‐metaiodobenzylguanidine (MIBG) scintigraphy is a valuable tool for differentiating neurodegenerative parkinsonism but interpretation can be difficult due to comorbidities and drug‐tracer interactions.
Frank Jagusch   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy